Tremor secondary prevention: Difference between revisions
Jump to navigation
Jump to search
Zehra Malik (talk | contribs) |
Zehra Malik (talk | contribs) |
||
| Line 15: | Line 15: | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
Effective measures for the secondary prevention of [[Parkinson's disease]] include: | Effective measures for the secondary prevention of [[Parkinson's disease]] include<ref name="pmid31706021">{{cite journal| author=Belvisi D, Pellicciari R, Fabbrini G, Tinazzi M, Berardelli A, Defazio G| title=Modifiable risk and protective factors in disease development, progression and clinical subtypes of Parkinson's disease: What do prospective studies suggest? | journal=Neurobiol Dis | year= 2020 | volume= 134 | issue= | pages= 104671 | pmid=31706021 | doi=10.1016/j.nbd.2019.104671 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31706021 }} </ref>: | ||
*[[Caffeine]] intake | *[[Caffeine]] intake | ||
*[[Physical activity]] | *[[Physical activity]] | ||
Revision as of 03:53, 1 February 2021
You can view and copy the source of this page.
|
Xyz Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Tremor secondary prevention On the Web |
|
American Roentgen Ray Society Images of Tremor secondary prevention |
|
Risk calculators and risk factors for Tremor secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
There are no established measures for the secondary prevention of [disease name].
OR
Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3].
Secondary Prevention
Effective measures for the secondary prevention of Parkinson's disease include[1]:
- Caffeine intake
- Physical activity
References
- ↑ Belvisi D, Pellicciari R, Fabbrini G, Tinazzi M, Berardelli A, Defazio G (2020). "Modifiable risk and protective factors in disease development, progression and clinical subtypes of Parkinson's disease: What do prospective studies suggest?". Neurobiol Dis. 134: 104671. doi:10.1016/j.nbd.2019.104671. PMID 31706021.